MX9205549A - Metodo para el tratamiento de vih. - Google Patents
Metodo para el tratamiento de vih.Info
- Publication number
- MX9205549A MX9205549A MX9205549A MX9205549A MX9205549A MX 9205549 A MX9205549 A MX 9205549A MX 9205549 A MX9205549 A MX 9205549A MX 9205549 A MX9205549 A MX 9205549A MX 9205549 A MX9205549 A MX 9205549A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- hiv
- undergoing
- compounds capable
- hiv infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76780291A | 1991-09-30 | 1991-09-30 | |
| US86521992A | 1992-04-08 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9205549A true MX9205549A (es) | 1993-05-01 |
Family
ID=27117960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9205549A MX9205549A (es) | 1991-09-30 | 1992-09-29 | Metodo para el tratamiento de vih. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0607252B1 (es) |
| JP (1) | JPH06511008A (es) |
| AT (1) | ATE173625T1 (es) |
| AU (1) | AU675412B2 (es) |
| BR (1) | BR9206571A (es) |
| CA (1) | CA2120140A1 (es) |
| DE (1) | DE69227696T2 (es) |
| MX (1) | MX9205549A (es) |
| OA (1) | OA09917A (es) |
| PT (1) | PT100914A (es) |
| WO (1) | WO1993006832A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9303854D0 (en) * | 1993-02-25 | 1993-04-14 | Holt John A G | Method for enhancing t-cell count |
| AU7931094A (en) * | 1993-10-15 | 1995-05-04 | Jess G. Thoene | Prevention of hiv infection |
| US5725870A (en) * | 1993-10-15 | 1998-03-10 | Thoene; Jess G. | Methods, composites and articles for contraception |
| WO1995020388A1 (fr) * | 1994-01-26 | 1995-08-03 | Nissui Pharmaceutical Co., Ltd. | Medicaments anti-vih |
| US5463122A (en) * | 1994-08-05 | 1995-10-31 | Warner-Lambert Company | Arylthio compounds |
| US5734081A (en) * | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
| US5846958A (en) * | 1995-02-17 | 1998-12-08 | U.S. Bioscience, Inc. | Methods of using aminothiols to promote hematopoietic progenitor cell growth |
| EP0868900A1 (de) * | 1997-03-14 | 1998-10-07 | Wella Aktiengesellschaft | Mittel und Verfahren zur daurerhaften Haarverformung |
| JP3012923B2 (ja) | 1998-01-26 | 2000-02-28 | 新潟大学長 | Ｃａｇリピート病の治療薬 |
| US6600076B1 (en) | 1999-04-05 | 2003-07-29 | The Regents Of The University Of California | Cleavable, water-soluble surfactants |
| WO2004024129A1 (en) * | 2002-09-10 | 2004-03-25 | Samir Chachoua | Induced remission therapy |
| AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| WO2010138419A2 (en) * | 2009-05-23 | 2010-12-02 | Obio Pharmaceutical (H.K.) Ltd. | Materials and methods for treating viral infections |
| WO2011046901A2 (en) * | 2009-10-12 | 2011-04-21 | Walker Dale M | Broad spectrum antiviral and methods of use |
| RU2022103033A (ru) * | 2015-07-02 | 2022-04-01 | ХОРАЙЗОН ОРФАН ЭлЭлСи | Цистеаминдиоксигеназа-резистентные аналоги цистеамина и их применение |
| MX2018011278A (es) | 2016-03-17 | 2019-07-08 | Thiogenesis Therapeutics Inc | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. |
| EP3684418A4 (en) | 2017-09-20 | 2021-06-16 | Thiogenesis Therapeutics, Inc. | TREATMENT METHODS FOR CYSTEAMINE SENSITIVE CONDITIONS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1055560B (it) * | 1974-05-02 | 1982-01-11 | Istituto Chemioterapico | Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali |
| EP0204989B1 (de) * | 1985-06-08 | 1992-03-25 | ASTA Medica Aktiengesellschaft | Verwendung von Penicillamin zur Behandlung von Immunmangelkrankheiten |
| CA1339256C (en) * | 1989-01-26 | 1997-08-12 | Wulf Droge | Treatment of diseases associated with hiv-infections |
| WO1990014007A1 (en) * | 1989-05-24 | 1990-11-29 | U.S. Bioscience | Method for protection from azt side effects and toxicity |
| WO1994004185A2 (en) * | 1992-08-19 | 1994-03-03 | Trustees Of Boston University | Method of inhibiting reduction of disulfide bonds |
-
1992
- 1992-09-29 PT PT100914A patent/PT100914A/pt not_active Application Discontinuation
- 1992-09-29 MX MX9205549A patent/MX9205549A/es unknown
- 1992-09-30 WO PCT/US1992/008156 patent/WO1993006832A1/en active IP Right Grant
- 1992-09-30 JP JP5506962A patent/JPH06511008A/ja active Pending
- 1992-09-30 DE DE69227696T patent/DE69227696T2/de not_active Expired - Fee Related
- 1992-09-30 AT AT92921278T patent/ATE173625T1/de not_active IP Right Cessation
- 1992-09-30 CA CA002120140A patent/CA2120140A1/en not_active Abandoned
- 1992-09-30 EP EP92921278A patent/EP0607252B1/en not_active Expired - Lifetime
- 1992-09-30 BR BR9206571A patent/BR9206571A/pt not_active Application Discontinuation
- 1992-09-30 AU AU27557/92A patent/AU675412B2/en not_active Ceased
-
1994
- 1994-03-28 OA OA60486A patent/OA09917A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0607252A1 (en) | 1994-07-27 |
| EP0607252B1 (en) | 1998-11-25 |
| EP0607252A4 (en) | 1996-03-13 |
| PT100914A (pt) | 1993-10-29 |
| BR9206571A (pt) | 1995-10-17 |
| AU2755792A (en) | 1993-05-03 |
| OA09917A (en) | 1994-09-15 |
| JPH06511008A (ja) | 1994-12-08 |
| ATE173625T1 (de) | 1998-12-15 |
| WO1993006832A1 (en) | 1993-04-15 |
| DE69227696D1 (de) | 1999-01-07 |
| DE69227696T2 (de) | 1999-05-20 |
| AU675412B2 (en) | 1997-02-06 |
| CA2120140A1 (en) | 1993-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9205549A (es) | Metodo para el tratamiento de vih. | |
| ES2067314T3 (es) | 3-benzacepin-zonas sustituidas por un grupo benzociclobutilo o indanil-alquil-amino-alquilo, utiles en el tratamiento de las afecciones cardiovasculares. | |
| CO4290353A1 (es) | Agonistas de estrogeno | |
| DK0582829T3 (da) | 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler | |
| ES2056963T3 (es) | Agentes antibacterianos. | |
| ATE30237T1 (de) | Epi-derivat von azahomoerythromycin a und zwischenprodukte. | |
| ES2055406T3 (es) | Composicion para el tratamiento de la inflamacion. | |
| ES532789A0 (es) | Procedimiento para el tratamiento de napas no-tejidas | |
| MX9305248A (es) | Compuestos de diarilpiperazinoacetamida. | |
| ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
| DK52487A (da) | Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser | |
| ES2013631B3 (es) | Metodo para el tratamiento de tejidos. | |
| MX9203629A (es) | Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b. | |
| ES520914A0 (es) | Procedimiento para el tratamiento de lodos industriales residuales. | |
| ES532696A0 (es) | Procedimiento para el tratamiento de textiles | |
| ES2052650T3 (es) | Derivados de la 2-pirimidinil-1-piperazina para el tratamiento del alcoholismo. | |
| ES2187534T3 (es) | Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida. | |
| ES2134184T3 (es) | Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica. | |
| ATE66610T1 (de) | Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen. | |
| NZ228023A (en) | 24(r)-scymnol; preparatory processes and pharmaceutical compositions | |
| MX9204286A (es) | Agentes para el tratamiento de semillas. | |
| ES2019583B3 (es) | Composicion para el tratamiento de infecciones. | |
| RU94020393A (ru) | Способ лечения вич-инфекций | |
| PT89582A (pt) | Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos | |
| ES1013369Y (es) | Maquina elaboradora para el tratamiento de superficies de piezas de trabajo. |